Tellgen Corporation (stock code: 300642) was established in 2003, specializing in the research and development, production, promotion, and sales of high-end in vitro diagnostic products.
The application of Tellgen products covers cancer prognosis, cardiovascular disease, autoimmune disease, pathogen infection, reproductive health, using multiplexed bead flow fluorescence, chemiluminescence, fluorescence PCR, and liquid chromatography with tandem mass spectrometry (LC-MS-MS).
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesIncluded in the Export Interest Directory?
NoProducts to be exported:
1. TESMI i100 Automatic Chemiluminescence Immunoassay Analyzer
2. AIGS Automated Integrated Gene Detection System
3. DP 96 Automated Workflow Series
4. Nuabox 1A Small Rapid Nucleic Acid Detection System
5. Nuabox 10B Small Rapid Nucleic Acid Detection System Business Needs:
Direct Sales, Distributor/Agent/Representative, Joint Ventures, Licensing Agreements